Stock Updates

How has UnitedHealth Group Incorporated:(NYSE:UNH) performed recently?

UnitedHealth Group Incorporated (NYSE: UNH) is a large market cap stock with a market cap of 129476.1. It is in the Health Care Plans industry and sector Healthcare, with a current P/E of 21.53, a forward P/E of 15.16 and EPS of 6.39. At a stock price of 137.6 (-0.41%) it has a dividend yield of 1.82%.

EPS growth for the last five years have been 8.00%, more recently this last year it has grown by 5.50%. The next year growth is going to be about 14.80% and more long-term 14.95% after five years. EPS growth quarter over quarter is 10.50%. Sales growth for the past five years have been 10.80% and sales growth quarter over quarter is 28.20%.

For performance, UnitedHealth Group Incorporated the past week has seen a gain of -2.00%. For the last month performance for UnitedHealth Group Incorporated is 1.67%. While the last quarter is -1.82% and half year, 9.45%. Finally for the year, performance is 20.67%.

The 52-week high for UnitedHealth Group Incorporated, is at -4.32%, and for the 52-week low it comes to a value of 29.70%. The 20-day simple moving average is -1.09% and 6.45% for the 200-day simple moving average.

Volatility for the week is at 1.56%, and for the month it is 1.45%. UnitedHealth Group Incorporated, has a target price of 161.95.

In terms of debt, long term debt/equity is 0.74, and for total debt/equity UnitedHealth Group Incorporated has 0.91. The gross margin is *TBA, while operating margin is 6.60%, the profit margin is 3.50%. The current ratio is *TBA and the quick ratio is *TBA.

Insider ownership is at 0.60%, with instituitional ownership at 88.80%. UnitedHealth Group Incorporated has a payout ratio of 32.70%. With the total shares outstanding coming to 940.96. The shares float is 936.48, with the float short at 0.80%, with short ratio coming to 2.54.

In terms of returns, the return on assets see UnitedHealth Group Incorporated, get 5.40%, with its returns on investment at 10.10%. Return on equity is 17.80%. So will the investors see the target price of 161.95, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment